This study is looking at whether cannabidiol (CBD) can help reduce fear in people with social anxiety disorder (SAD). You would be randomly assigned to receive either oral cannabidiol capsules or a placebo (an inactive capsule). Researchers will then see if cannabidiol helps you reduce your fear response during a specific task where you learn to overcome fear. Success in this study means participants taking CBD show lower skin conductance (a measure of anxiety) and report less distress during this task. The study plans to enroll 20 participants, but its current status is unclear.

Study design

This is a randomized, double-blind study, meaning participants are randomly assigned to a group and neither you nor the researchers will know if you're receiving cannabidiol or placebo. It plans to include 20 participants.

What's involved

You would participate in a single 2.5-hour session. This includes a fear conditioning task where you receive mild electrical stimulation paired with angry faces, then take the study medication, and finally undergo a fear extinction phase.

Compensation

Not stated in the trial record.

Follow-up

Your skin conductance and distress ratings will be measured during a single 2.5-hour session.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.